These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 1695325

  • 1. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF.
    N Engl J Med; 1990 Aug 09; 323(6):366-72. PubMed ID: 1695325
    [Abstract] [Full Text] [Related]

  • 2. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA, Brugnara C, Dover GJ, Schapira L, Lacroix L, Bunn HF.
    Semin Oncol; 1992 Jun 09; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [Abstract] [Full Text] [Related]

  • 3. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 4. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP.
    Semin Oncol; 1992 Jun 14; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [Abstract] [Full Text] [Related]

  • 5. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1990 Apr 12; 322(15):1037-45. PubMed ID: 1690857
    [Abstract] [Full Text] [Related]

  • 6. Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.
    McDonagh KT, Dover GJ, Donahue RE, Nathan DG, Agricola B, Byrne E, Nienhuis AW.
    Exp Hematol; 1992 Nov 12; 20(10):1156-64. PubMed ID: 1385194
    [Abstract] [Full Text] [Related]

  • 7. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
    el-Hazmi MA, al-Momen A, Warsy AS, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F.
    Acta Haematol; 1995 Nov 12; 93(2-4):57-61. PubMed ID: 7543719
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia.
    al-Khatti A, Umemura T, Clow J, Abels RI, Vance J, Papayannopoulou T, Stamatoyannopoulos G.
    Trans Assoc Am Physicians; 1988 Nov 12; 101():54-61. PubMed ID: 2480020
    [No Abstract] [Full Text] [Related]

  • 9. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.
    Blood Cells Mol Dis; 2000 Oct 12; 26(5):453-66. PubMed ID: 11112383
    [Abstract] [Full Text] [Related]

  • 10. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP.
    Medicine (Baltimore); 1996 Nov 12; 75(6):300-26. PubMed ID: 8982148
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons.
    Al-Khatti A, Veith RW, Papayannopoulou T, Fritsch EF, Goldwasser E, Stamatoyannopoulos G.
    N Engl J Med; 1987 Aug 13; 317(7):415-20. PubMed ID: 2441258
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G.
    N Engl J Med; 1985 Dec 19; 313(25):1571-5. PubMed ID: 2415821
    [Abstract] [Full Text] [Related]

  • 13. Hydroxyurea in the treatment of sickle-cell anemia.
    Howard LW, Kennedy LD.
    Ann Pharmacother; 1997 Nov 19; 31(11):1393-6. PubMed ID: 9391697
    [Abstract] [Full Text] [Related]

  • 14. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.
    Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, Sable C, Darbari D, Dham N, Onyekwere O, Ammosova T, Nekhai S, Kato GJ, Gladwin MT, Castro OL.
    Blood; 2009 Nov 19; 114(21):4639-44. PubMed ID: 19724057
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH, Al-Dabbous IA.
    Saudi Med J; 2002 Mar 19; 23(3):277-81. PubMed ID: 11938415
    [Abstract] [Full Text] [Related]

  • 16. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
    Orringer EP, Blythe DS, Johnson AE, Phillips G, Dover GJ, Parker JC.
    Blood; 1991 Jul 01; 78(1):212-6. PubMed ID: 1712641
    [Abstract] [Full Text] [Related]

  • 17. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
    Rodgers GP.
    Semin Hematol; 1997 Jul 01; 34(3 Suppl 3):2-7. PubMed ID: 9317195
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea therapy in thalassemia.
    Loukopoulos D, Voskaridou E, Stamoulakatou A, Papassotiriou Y, Kalotychou V, Loutradi A, Cozma G, Tsiarta H, Pavlides N.
    Ann N Y Acad Sci; 1998 Jun 30; 850():120-8. PubMed ID: 9668534
    [Abstract] [Full Text] [Related]

  • 19. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
    Ballas SK, McCarthy WF, Guo N, Brugnara C, Kling G, Bauserman RL, Waclawiw MA.
    Hemoglobin; 2010 Jun 30; 34(5):424-9. PubMed ID: 20854115
    [Abstract] [Full Text] [Related]

  • 20. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984 Jun 30; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.